Literature DB >> 24226304

Lower provider volume is associated with higher failure rates for endoscopic retrograde cholangiopancreatography.

Gregory A Coté1, Timothy D Imler, Huiping Xu, Evgenia Teal, Dustin D French, Thomas F Imperiale, Marc B Rosenman, Jeffery Wilson, Siu L Hui, Stuart Sherman.   

Abstract

BACKGROUND: Among physicians who perform endoscopic retrograde cholangiopancreatography (ERCP), the relationship between procedure volume and outcome is unknown.
OBJECTIVE: Quantify the ERCP volume-outcome relationship by measuring provider-specific failure rates, hospitalization rates, and other quality measures. RESEARCH
DESIGN: Retrospective cohort.
SUBJECTS: A total of 16,968 ERCPs performed by 130 physicians between 2001 and 2011, identified in the Indiana Network for Patient Care. MEASURES: Physicians were classified by their average annual Indiana Network for Patient Care volume and stratified into low (<25/y) and high (≥25/y). Outcomes included failed procedures, defined as repeat ERCP, percutaneous transhepatic cholangiography or surgical exploration of the bile duct≤7 days after the index procedure, hospitalization rates, and 30-day mortality.
RESULTS: Among 15,514 index ERCPs, there were 1163 (7.5%) failures; the failure rate was higher among low (9.5%) compared with high volume (5.7%) providers (P<0.001). A second ERCP within 7 days (a subgroup of failure rate) occurred more frequently when the original ERCP was performed by a low-volume (4.1%) versus a high-volume physician (2.3%, P=0.013). Patients were more frequently hospitalized within 24 hours when the ERCP was performed by a low-volume (28.3%) versus high-volume physician (14.8%, P=0.002). Mortality within 30 days was similar (low=1.9%, high=1.9%). Among low-volume physicians and after adjusting, the odds of having a failed procedure decreased 3.3% (95% confidence interval, 1.6%-5.0%, P<0.001) with each additional ERCP performed per year.
CONCLUSIONS: Lower provider volume is associated with higher failure rate for ERCP, and greater need for postprocedure hospitalization.

Entities:  

Mesh:

Year:  2013        PMID: 24226304      PMCID: PMC3830424          DOI: 10.1097/MLR.0b013e3182a502dc

Source DB:  PubMed          Journal:  Med Care        ISSN: 0025-7079            Impact factor:   2.983


  32 in total

1.  Trends in hospital volume and operative mortality for high-risk surgery.

Authors:  Jonathan F Finks; Nicholas H Osborne; John D Birkmeyer
Journal:  N Engl J Med       Date:  2011-06-02       Impact factor: 91.245

2.  Individual and practice differences among physicians who perform ERCP at varying frequency: a national survey.

Authors:  Gregory A Coté; Rajesh N Keswani; Tina Jackson; Evan Fogel; Glen A Lehman; Lee McHenry; James Watkins; Stuart Sherman
Journal:  Gastrointest Endosc       Date:  2011-04-14       Impact factor: 9.427

3.  The ERCP quality network: a pilot study of benchmarking practice and performance.

Authors:  Peter B Cotton; Joseph Romagnuolo; Douglas O Faigel; Guiseppe Aliperti; Stephen E Deal
Journal:  Am J Med Qual       Date:  2012-08-28       Impact factor: 1.852

4.  Association between volume of endoscopic retrograde cholangiopancreatography at an academic medical center and use of pancreatobiliary therapy.

Authors:  Gregory A Coté; Sanjeev Singh; Lois G Bucksot; Laura Lazzell-Pannell; Suzette E Schmidt; Evan Fogel; Lee McHenry; James Watkins; Glen Lehman; Stuart Sherman
Journal:  Clin Gastroenterol Hepatol       Date:  2012-03-02       Impact factor: 11.382

5.  Can endoscopic ultrasound or magnetic resonance cholangiopancreatography replace ERCP in patients with suspected biliary disease? A prospective trial and cost analysis.

Authors:  J M Scheiman; R C Carlos; J L Barnett; G H Elta; T T Nostrant; W D Chey; I R Francis; P S Nandi
Journal:  Am J Gastroenterol       Date:  2001-10       Impact factor: 10.864

6.  Risk factors for post-ERCP pancreatitis: a prospective, multicenter study.

Authors:  M L Freeman; J A DiSario; D B Nelson; M B Fennerty; J G Lee; D J Bjorkman; C S Overby; J Aas; M E Ryan; G S Bochna; M J Shaw; H W Snady; R V Erickson; J P Moore; J P Roel
Journal:  Gastrointest Endosc       Date:  2001-10       Impact factor: 9.427

7.  ERCP procedures in a Finnish community hospital: a retrospective analysis of 1207 cases.

Authors:  A Siiki; A Tamminen; T Tomminen; P Kuusanmäki
Journal:  Scand J Surg       Date:  2012       Impact factor: 2.360

8.  The association between hospital volume and processes, outcomes, and costs of care for congestive heart failure.

Authors:  Karen E Joynt; E John Orav; Ashish K Jha
Journal:  Ann Intern Med       Date:  2011-01-18       Impact factor: 25.391

9.  Burden of gastrointestinal disease in the United States: 2012 update.

Authors:  Anne F Peery; Evan S Dellon; Jennifer Lund; Seth D Crockett; Christopher E McGowan; William J Bulsiewicz; Lisa M Gangarosa; Michelle T Thiny; Karyn Stizenberg; Douglas R Morgan; Yehuda Ringel; Hannah P Kim; Marco Dacosta DiBonaventura; Charlotte F Carroll; Jeffery K Allen; Suzanne F Cook; Robert S Sandler; Michael D Kappelman; Nicholas J Shaheen
Journal:  Gastroenterology       Date:  2012-08-08       Impact factor: 22.682

10.  Regionalization of high-risk surgery and implications for patient travel times.

Authors:  John D Birkmeyer; Andrea E Siewers; Nancy J Marth; David C Goodman
Journal:  JAMA       Date:  2003-11-26       Impact factor: 56.272

View more
  23 in total

1.  Low ERCP Volume Is Associated with More Industry Representative Interactions but Similar Training of Nurses.

Authors:  Rajesh N Keswani; Phyllis Malpas; Sheryl E Lynch; Gregory A Coté
Journal:  Dig Dis Sci       Date:  2015-10-27       Impact factor: 3.199

2.  Hospital Surgical Volume and Associated Postoperative Complications of Pediatric Urological Surgery in the United States.

Authors:  Hsin-Hsiao S Wang; Rohit Tejwani; Haijing Zhang; John S Wiener; Jonathan C Routh
Journal:  J Urol       Date:  2015-01-29       Impact factor: 7.450

3.  Quality indicators for ERCP.

Authors:  Douglas G Adler; John G Lieb; Jonathan Cohen; Irving M Pike; Walter G Park; Maged K Rizk; Mandeep S Sawhney; James M Scheiman; Nicholas J Shaheen; Stuart Sherman; Sachin Wani
Journal:  Am J Gastroenterol       Date:  2014-12-02       Impact factor: 10.864

4.  ERCP and Mortality.

Authors:  Steven J Heitman
Journal:  Gastroenterol Hepatol (N Y)       Date:  2014-11

5.  Volume, specialty background, practice pattern, and outcomes in endoscopic retrograde cholangiopancreatography: an analysis of the national inpatient sample.

Authors:  Jac Cooper; Sapan Desai; Steve Scaife; Chad Gonczy; John Mellinger
Journal:  Surg Endosc       Date:  2016-11-04       Impact factor: 4.584

6.  Effects of a Brief Educational Program on Optimization of Fluoroscopy to Minimize Radiation Exposure During Endoscopic Retrograde Cholangiopancreatography.

Authors:  Monique T Barakat; Nirav C Thosani; Robert J Huang; Abhishek Choudhary; Rajan Kochar; Shivangi Kothari; Subhas Banerjee
Journal:  Clin Gastroenterol Hepatol       Date:  2017-08-10       Impact factor: 11.382

Review 7.  A Multidisciplinary Approach to Pancreas Cancer in 2016: A Review.

Authors:  Evan L Fogel; Safi Shahda; Kumar Sandrasegaran; John DeWitt; Jeffrey J Easler; David M Agarwal; Mackenzie Eagleson; Nicholas J Zyromski; Michael G House; Susannah Ellsworth; Ihab El Hajj; Bert H O'Neil; Attila Nakeeb; Stuart Sherman
Journal:  Am J Gastroenterol       Date:  2017-01-31       Impact factor: 10.864

8.  Provider-specific quality measurement for ERCP using natural language processing.

Authors:  Timothy D Imler; Stuart Sherman; Thomas F Imperiale; Huiping Xu; Fangqian Ouyang; Christopher Beesley; Charity Hilton; Gregory A Coté
Journal:  Gastrointest Endosc       Date:  2017-05-03       Impact factor: 9.427

9.  Hospital volume status is related to technical failure and all-cause mortality following ERCP for benign disease.

Authors:  Evangelos Kalaitzakis; Ervin Toth
Journal:  Dig Dis Sci       Date:  2015-01-06       Impact factor: 3.199

10.  Endoscopic treatment of acute biliary diseases: have we optimized the value of inpatient endoscopic retrograde cholangiopancreatography?

Authors:  Gregory A Coté
Journal:  Clin Gastroenterol Hepatol       Date:  2013-11-19       Impact factor: 11.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.